On osteoclast precursor cells and mature rat osteoclasts, 7 days of EGCG treatment with a dose of 10 and 100 μM restrained multinucleated osteoclast formation, MMP-9, and MMP-2, showing anti-RA effects [36]. The gene discussed is MMP2; the disease is rheumatoid arthritis.